High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease

Lung India

Volumn 29, Issue 1, 2012, Pages 24-29

  Nillawar, Anup N ^a   Bardapurkar, J S ^a   Bardapurkar, S J ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b Shree Nursing Home ^*  (India)

Author keywords

COPD; hs CRP; LDH 3 isoenzyme

Indexed keywords

C REACTIVE PROTEIN; CELL ENZYME; LACTATE DEHYDROGENASE ISOENZYME; LACTATE DEHYDROGENASE ISOENZYME 3; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHEMICAL ANALYSIS; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EXTRACELLULAR SPACE; FORCED EXPIRATORY VOLUME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG FUNCTION TEST; MALE; PROFESSIONAL STANDARD; PROTEIN BLOOD LEVEL; SMOKING;

EID: 84856597905     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.92358     Document Type: Article

References (26)

1. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D,et al. Multicentric Study on epidemiology of Chronic Obstructive Pulmonary Disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23-9.
2. Goldcopd.com (Internet) 2005 update: executive Summary, Global Strategy for the Diagnosis, Management, and prevention of COPD; September 2005. Available from: http://www.goldcopd.com/[Last accessed on 2005].
3. Groneberg DA, Chung KF. Models of chronic obstructive pulmonary disease. Respir Res 2004;5:18.
4. Rufno R, Lapa e Silva JR. Cellular and biochemical bases of chronic obstructive pulmonary disease. J Bras Pneumol 2006; 32:241-8.
5. van Eeden SF, Yeung A, Quinlam K, Hogg JC. Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease.Proc Am Thorac Soc 2005;2:61-7. (Pubitemid 40562964)
6. th ed. St.Louis,MO: Elsevier Saunders.
7. Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or infammation. Eur Respir J 1996;9:1736-42. (Pubitemid 26271162)
8. Lott JA, Nemensanszky E. Lactate dehydrogenase. In: Lott JA. Wolf L.editors Clinical enzymology, a case - oriented approach.New York: Field, rich and associates, Inc.,1987. p. 213-44.
9. Kachmar JF, Moss DW.In Enzymes. In: Tietz NW, Editor. Fundamentals of clinical chemistry, Philadelphia:Saunders; 1976. p. 652-60.
10. Moses GC, Ross ML, Henderson AR. Ten electrophoretic methods compared with a selected method for quantifying lactate dehydrogenase isoenzymes in serum. Clin Chem 1988;34:1885-90.
11. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C- reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25. (Pubitemid 32222454)
12. th Ed.New York City, McGraw-Hill; 2005. p.1548-52.
13. Cobben NA, Drent M, Schols AM, Lamers RJ, Wouters EF, van Diejien-Visser MP. Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers. Respir Med 1997;91:616-23. (Pubitemid 27453660)
14. DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 1986;204:236-40.
15. Matusiewicz SP, Williamson IJ, Sime PJ, Brown PH, Wenham PR, Crompton GK, et al. Plasma lactate dehydrogenase: A marker of disease activity in cryptogenic fbrosing alveolitis and extrinsic allergic alveolitis. Eur Respir J 1993;6:1282-6. (Pubitemid 23329543)
16. Cobben NA, Jacobs JA, van Dieijen-Visser MP, Mulder PG,Wouters EF, Drent M. Diagnostic value of BAL fuid cellular profle and enzymes in infectious pulmonary disorders. Eur Respir J 1999;14:496-502. (Pubitemid 29479710)
17. Drent M, Cobben NA, Henderson RF, Jacobs JA, Wouters EF, van Dieijen-Visser MP.BAL fuid LDH activity and LDH isoenzyme pattern in lipoid pneumonia caused by anintravenous injection of lamp oil. Eur Respir J 1996;9:2416-8. (Pubitemid 26366675)
18. Chumbalkar VC. Lactate dehydrogenase enzyme -6: Evaluations in clinical medicine and its partial characterization. [Dissertation] MD (Biochemistry) Pune University; 2000.
19. Gan WQ, Man SF, Senthilselvan A, SinDD. Association between chronic obstructive pulmonary disease and systemic infammation: A systematic review and a meta-analysis. Thorax 2004;59:574-80. (Pubitemid 38901515)
20. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.Thorax 2006;61:849-53. (Pubitemid 44570304)
21. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non- smokers. Thorax 2006;61:23-28. (Pubitemid 43106973)
22. Balasubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs.Curr Opin Pulm Med 2006;12:106-12. (Pubitemid 44384784)
23. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolicandfunctionalimpairment in advanced COPD. Thorax 2006;61:1-3.
24. Wouters EF.Local and Systemic Infammation in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2005;2:26-33. (Pubitemid 40562960)
25. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of infammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51:819-24. (Pubitemid 26274084)
26. Yasuda N, Goth K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, et al. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 1998;92:993-9. (Pubitemid 28416826)